The Prognosis of Stage IA Synchronous Endometrial Endometrioid and Ovarian Carcinomas

Archives of Gynecology and Obstetrics - Germany
doi 10.1007/s00404-019-05288-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry

Frontiers in Oncology
Cancer ResearchOncology
2020English

Is P53 Overexpression a Predictor of Worse Outcomes in Endometrioid Endometrial Carcinomas?

International Journal of Pathology and Clinical Research
2018English

Synchronous Primary Endometrial and Ovarian Cancers: A Critical Update

International Journal of Gynecology & Clinical Practices
2015English

ARID1A Loss Is Prevalent in Endometrial Hyperplasia With Atypia and Low-Grade Endometrioid Carcinomas

Modern Pathology
Forensic MedicinePathology
2012English

Low-Stage High-Grade Serous Ovarian Carcinomas

International Journal of Gynecological Pathology
GynecologyForensic MedicinePathologyObstetrics
2016English

Association of miRNA-200c Expression Levels With Clinicopathological Factors and Prognosis in Endometrioid Endometrial Cancer

Acta Obstetricia et Gynecologica Scandinavica
MedicineGynecologyObstetrics
2018English

Evidence for Divergence of DNA Copy Number Changes in Serous, Mucinous and Endometrioid Ovarian Carcinomas

British Journal of Cancer
Cancer ResearchOncology
1997English

Mitochondrial DNA Genotyping Efficiently Reveals Clonality of Synchronous Endometrial and Ovarian Cancers

Modern Pathology
Forensic MedicinePathology
2014English

Synchronous Endometrial and Ovarian Cancer in Young Women: Case Report and Review of the Literature

Anticancer Research
MedicineCancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy